InvestSMART

Kazia Therapeutics Limited (ASX: KZA) - Announcements

DELISTED - Current share price for KZA : $0.080

ASX company news and announcements for Kazia Therapeutics Limited (KZA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Kazia Therapeutics Limited (KZA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Kazia Therapeutics Limited (KZA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Kazia Therapeutics Limited (KZA)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
- Appendix 2A 28 Apr 2021 12:27PM $1.375 $0.080 fallen by 94.18%
- Kazia Corporate Presentation 19 Apr 2021 5:25PM $1.530 $0.080 fallen by 94.77%
- Kazia licenses EVT801 from Evotec 19 Apr 2021 5:17PM $1.530 $0.080 fallen by 94.77%
- Trading Halt 16 Apr 2021 8:54AM $1.530 $0.080 fallen by 94.77%
- Kazia presents PK data for paxalisib at AACR meeting 9 Apr 2021 8:23AM $1.880 $0.080 fallen by 95.74%
- Change in substantial holding 8 Apr 2021 5:15PM $1.880 $0.080 fallen by 95.74%
- Change in substantial holding 30 Mar 2021 8:24AM $1.450 $0.080 fallen by 94.48%
- Proposed issue of Securities - KZA 30 Mar 2021 8:20AM $1.450 $0.080 fallen by 94.48%
- Proposed issue of Securities - KZA 30 Mar 2021 8:19AM $1.450 $0.080 fallen by 94.48%
- Kazia licenses paxalisib to Simcere in Greater China 29 Mar 2021 7:05PM $1.450 $0.080 fallen by 94.48%
- Trading Halt 26 Mar 2021 9:01AM $1.450 $0.080 fallen by 94.48%
- Kazia March Newsletter 18 Mar 2021 9:33AM $1.345 $0.080 fallen by 94.05%
- Appendix 2A 15 Mar 2021 6:02PM $1.320 $0.080 fallen by 93.94%
- Proposed issue of Securities - KZA 15 Mar 2021 11:46AM $1.325 $0.080 fallen by 93.96%
- Appendix 2A 2 Mar 2021 9:17AM $1.280 $0.080 fallen by 93.75%
- Kazia licenses Cantrixil to Oasmia 1 Mar 2021 4:55PM $1.280 $0.080 fallen by 93.75%
- Change in substantial holding 26 Feb 2021 8:13AM $1.370 $0.080 fallen by 94.16%
- Proposed issue of Securities - KZA 25 Feb 2021 10:38AM $1.390 $0.080 fallen by 94.24%
- Kazia half year accounts and Appx 4D 24 Feb 2021 4:16PM $1.315 $0.080 fallen by 93.92%
- Change in substantial holding 11 Feb 2021 4:26PM $1.280 $0.080 fallen by 93.75%
- Appendix 4C - quarterly 29 Jan 2021 9:17AM $1.215 $0.080 fallen by 93.42%
- Kazia presents to ShareCafe Hidden Gems webinar 22 Jan 2021 9:26AM $1.280 $0.080 fallen by 93.75%
- Kazia commences recruitment to GBM AGILE 7 Jan 2021 9:32AM $1.240 $0.080 fallen by 93.55%
- Kazia presents to HCW BIOCONNECT 5 Jan 2021 10:04AM $1.185 $0.080 fallen by 93.25%
- Appendix 3G Issue of staff options 4 Jan 2021 1:00PM $1.165 $0.080 fallen by 93.13%

226 - 250 of 476 results

Page 10 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.